Fig. 1

Change in lipid parameters from baseline through the third follow-up visit among those with lipid-specific abnormal levels at baseline and stratified by health insurance payer type. a) Mean change in LDL-C (mg/dL) from baseline through the third follow-up visit; b) Mean change in HDL-C (mg/dL) from baseline through the third follow-up visit; c) Mean change in non-HDL-C (mg/dL) from baseline through the third follow-up visit; d) Mean change in triglyceride level (mg/dL) from baseline through the third follow-up visit. All data presented are mean and 95% confidence intervals. HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein